Lv4
540 积分 2023-01-18 加入
Rituximab as the first-line therapy in anti-synthetase syndrome-related interstitial lung disease
1年前
已完结
The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review
1年前
已完结
Identification and Prognosis of Patients With Interstitial Pneumonia With Autoimmune Features
1年前
已完结
A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease
1年前
已完结
Nomogram to predict dermatomyositis prognosis: a population-based study of 457 cases
1年前
已完结
Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
1年前
已完结
Clinical and prognostic features associated with anti-Ro52 autoantibodies in connective tissue diseases patients with interstitial lung disease
1年前
已完结
Clinical manifestations and outcome of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody positive patients with interstitial lung disease
1年前
已完结
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients
1年前
已完结
Idiopathic inflammatory myopathies
1年前
已完结
皖公网安备34019202002308
